SK287717B6 - Use of FSH for treating infertility and/or its biologically active analogue - Google Patents

Use of FSH for treating infertility and/or its biologically active analogue Download PDF

Info

Publication number
SK287717B6
SK287717B6 SK1096-2002A SK10962002A SK287717B6 SK 287717 B6 SK287717 B6 SK 287717B6 SK 10962002 A SK10962002 A SK 10962002A SK 287717 B6 SK287717 B6 SK 287717B6
Authority
SK
Slovakia
Prior art keywords
dose
fsh
days
day
treatment
Prior art date
Application number
SK1096-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK10962002A3 (sk
Inventor
Louise DUERR-MYERS
Ernest Loumaye
Original Assignee
Serono Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26072975&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK287717(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP00302840A external-priority patent/EP1142582A1/de
Application filed by Serono Lab filed Critical Serono Lab
Publication of SK10962002A3 publication Critical patent/SK10962002A3/sk
Publication of SK287717B6 publication Critical patent/SK287717B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK1096-2002A 2000-01-27 2001-01-09 Use of FSH for treating infertility and/or its biologically active analogue SK287717B6 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00300591 2000-01-27
EP00302840A EP1142582A1 (de) 2000-04-04 2000-04-04 Verwendung von FSH zur Behandlung von Infertilität
PCT/GB2001/000065 WO2001054715A1 (en) 2000-01-27 2001-01-09 Use of fsh for treating infertility

Publications (2)

Publication Number Publication Date
SK10962002A3 SK10962002A3 (sk) 2002-12-03
SK287717B6 true SK287717B6 (en) 2011-07-06

Family

ID=26072975

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1096-2002A SK287717B6 (en) 2000-01-27 2001-01-09 Use of FSH for treating infertility and/or its biologically active analogue

Country Status (29)

Country Link
US (1) US7291593B2 (de)
EP (2) EP1442748A1 (de)
JP (1) JP5170928B2 (de)
KR (2) KR100871502B1 (de)
CN (1) CN1418107A (de)
AR (1) AR027287A1 (de)
AT (1) ATE267608T1 (de)
AU (1) AU783121B2 (de)
BG (1) BG65915B1 (de)
BR (1) BR0107881A (de)
CA (1) CA2397680A1 (de)
CZ (1) CZ302835B6 (de)
DE (1) DE60103503T3 (de)
DK (1) DK1250148T4 (de)
EA (1) EA004924B1 (de)
EE (1) EE05444B1 (de)
ES (1) ES2217113T5 (de)
HR (1) HRP20020630A2 (de)
HU (1) HU230833B1 (de)
IL (2) IL150837A0 (de)
MX (1) MXPA02007233A (de)
NO (1) NO324626B1 (de)
PL (1) PL211113B1 (de)
PT (1) PT1250148E (de)
RS (1) RS50805B (de)
SI (1) SI1250148T2 (de)
SK (1) SK287717B6 (de)
TR (1) TR200401810T4 (de)
WO (1) WO2001054715A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002324183B2 (en) * 2001-09-12 2007-10-25 Merck Serono Sa Use of hCG and LH in controlled ovarian hyperstimulation
RS21004A (en) * 2001-09-12 2006-12-15 Aplied Research Systems Ars Holding N.V. Use of hcg in controlled ovarian hyperstimulation
CN100376289C (zh) * 2001-09-12 2008-03-26 应用研究系统Ars股份公司 人绒毛膜促性腺激素和黄体生成激素在控制性超排卵中的应用
UA88879C2 (en) * 2003-09-02 2009-12-10 Эплайд Рисерч Системз Эрс Холдинг Н.В. Fsh glycosylation mutant
US7481748B2 (en) * 2005-09-22 2009-01-27 Kurt Manufacturing Company, Inc. Locking mechanism for a bicycle trainer
WO2008140794A1 (en) * 2007-05-11 2008-11-20 The Texas A & M University System Hormone normalization therapy and uses thereof
AR081755A1 (es) * 2010-04-02 2012-10-17 Hanmi Holdings Co Ltd Formulacion de accion prolongada de la hormona estimuladora de los foliculos donde se usa un fragmento de inmunoglobulina, metodo de preparacion y metodo para tratar a un sujeto que sufre un trastorno reproductivo
WO2015089656A1 (en) * 2013-12-20 2015-06-25 Fertilify Inc. Compositions comprising vitamin c, vitamin e, and coenzyme q10 and use thereof for promoting female fertility and reproductive health
CA3073624A1 (en) * 2017-09-01 2019-03-07 Ferring B.V. Composition for controlled ovarian stimulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725579A (en) * 1985-02-21 1988-02-16 Serono Laboratories, Inc. Method of in vitro fertilization by a unique combination of gonadotropins

Also Published As

Publication number Publication date
JP5170928B2 (ja) 2013-03-27
DK1250148T3 (da) 2004-08-16
IL150837A (en) 2010-12-30
KR20020081273A (ko) 2002-10-26
BG106943A (bg) 2003-02-28
CZ302835B6 (cs) 2011-11-30
ES2217113T5 (es) 2008-11-01
SK10962002A3 (sk) 2002-12-03
HUP0204324A3 (en) 2004-12-28
NO324626B1 (no) 2007-11-26
BR0107881A (pt) 2003-04-01
CA2397680A1 (en) 2001-08-02
CN1418107A (zh) 2003-05-14
WO2001054715A1 (en) 2001-08-02
EP1250148A1 (de) 2002-10-23
EA004924B1 (ru) 2004-10-28
KR100871499B1 (ko) 2008-12-05
KR20070087253A (ko) 2007-08-27
PT1250148E (pt) 2004-09-30
PL356925A1 (en) 2004-07-12
RS50805B (sr) 2010-08-31
KR100871502B1 (ko) 2008-12-05
SI1250148T1 (en) 2004-08-31
BG65915B1 (bg) 2010-05-31
US20030158106A1 (en) 2003-08-21
DK1250148T4 (da) 2008-09-22
PL211113B1 (pl) 2012-04-30
AU783121B2 (en) 2005-09-29
JP2003520823A (ja) 2003-07-08
TR200401810T4 (tr) 2004-09-21
EE05444B1 (et) 2011-08-15
YU56702A (sh) 2005-09-19
HRP20020630A2 (en) 2004-12-31
MXPA02007233A (es) 2003-02-12
EP1250148B1 (de) 2004-05-26
IL150837A0 (en) 2003-02-12
AR027287A1 (es) 2003-03-19
HU230833B1 (hu) 2018-07-30
NO20023354D0 (no) 2002-07-11
EP1442748A1 (de) 2004-08-04
ATE267608T1 (de) 2004-06-15
EP1250148B2 (de) 2008-07-02
AU2532101A (en) 2001-08-07
HUP0204324A2 (en) 2003-05-28
EE200200415A (et) 2003-12-15
DE60103503D1 (de) 2004-07-01
NO20023354L (no) 2002-09-24
US7291593B2 (en) 2007-11-06
EA200200801A1 (ru) 2003-02-27
SI1250148T2 (sl) 2008-10-31
DE60103503T3 (de) 2008-12-24
CZ20022555A3 (cs) 2002-11-13
ES2217113T3 (es) 2004-11-01
DE60103503T2 (de) 2005-06-09

Similar Documents

Publication Publication Date Title
US7291593B2 (en) Use of fish for treating infertility
EP1511537B1 (de) Verfahren zur konstrollierten ovariellen hyperstimulation und pharmazeutisches set zur verwendung bei diesem verfahren
JP2003520823A5 (de)
EP4157323A1 (de) Zusammensetzung mit hp-hmg zur verwendung bei der behandlung von unfruchtbarkeit
AU2005203211B2 (en) Use of FSH for treating infertility
EP1142582A1 (de) Verwendung von FSH zur Behandlung von Infertilität
US20230248807A1 (en) Hp-hmg for use in the treatment of infertility in a patient with polycystic ovary syndrome
EP3932419A1 (de) Verfahren zur behandlung von unfruchtbarkeit

Legal Events

Date Code Title Description
TC4A Change of owner's name

Owner name: MERCK SERONO SA, COINSINS, VAUD, CH

Effective date: 20120709

MK4A Expiry of patent

Expiry date: 20210109